EWM
ABBV icon

Edge Wealth Management’s AbbVie ABBV Stock Holding History

Edge Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-970
Closed -$131K – 95
2021
Q4 		$131K Hold
970
– – 0.02% 115
2021
Q3 		$105K Buy
970
+39
+4% +$4.46K 0.02% 128
2021
Q2 		$105K Hold
931
– – 0.02% 133
2021
Q1 		$101K Buy
931
+48
+5% +$5.13K 0.02% 137
2020
Q4 		$94K Hold
883
– – 0.02% 136
2020
Q3 		$77K Sell
883
-650
-42% -$61.2K 0.02% 169
2020
Q2 		$151K Buy
1,533
+324
+27% +$28.5K 0.03% 163
2020
Q1 		$93K Buy
1,209
+400
+49% +$34.1K 0.02% 179
2019
Q4 		$71K Buy
809
+236
+41% +$19.6K 0.01% 226
2019
Q3 		$43K Buy
573
+295
+106% +$20.2K 0.01% 259
2019
Q2 		$20K Buy
+278
New +$21.9K ﹤0.01% 336
2018
Q2 		– Sell
-1,000
Closed -$95K – 585
2018
Q1 		$95K Buy
1,000
+900
+900% +$98.9K 0.03% 164
2017
Q4 		$9K Buy
+100
New +$9.43K ﹤0.01% 388
2016
Q4 		– Sell
-100,916
Closed -$6.29M – 497
2016
Q3 		$6.29M Sell
100,916
-40,316
-29% -$2.61M 2.68% 12
2016
Q2 		$8.74M Sell
141,232
-19,710
-12% -$1.2M 3.64% 7
2016
Q1 		$9.19M Sell
160,942
-7,941
-5% -$443K 4.17% 4
2015
Q4 		$10.1M Sell
168,883
-4,760
-3% -$274K 3.79% 5
2015
Q3 		$9.3M Sell
173,643
-888
-0.5% -$57.8K 3.5% 7
2015
Q2 		$11.7M Sell
174,531
-17,101
-9% -$1.12M 4.01% 3
2015
Q1 		$11.2M Buy
191,632
+27,964
+17% +$1.69M 3.78% 6
2014
Q4 		$10.9M Buy
163,668
+1,467
+0.9% +$92.5K 3.98% 8
2014
Q3 		$9.4M Buy
162,201
+1,107
+0.7% +$61.5K 3.62% 8
2014
Q2 		$9.09M Buy
161,094
+128,775
+398% +$6.76M 3.78% 8
2014
Q1 		$1.66M Sell
32,319
-7,335
-18% -$371K 0.7% 29
2013
Q4 		$2.09M Buy
39,654
+8,790
+28% +$432K 0.97% 26
2013
Q3 		$1.38M Buy
30,864
+3,935
+15% +$174K 0.84% 26
2013
Q2 		$1.13M Buy
+26,929
New +$1.18M 0.76% 27

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Edge Wealth Management's ABBV Position: Q1 2022 in Review

Edge Wealth Management sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 970 shares — an estimated $131K sold.

Edge Wealth Management first reported a position in ABBV in Q2 2013 and held it in 27 quarters. The position peaked at $11.7M in Q2 2015. 3,051 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Edge Wealth Management reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Edge Wealth Management sold 970 AbbVie shares in Q1 2022, an estimated $131K.
  • Edge Wealth Management first reported a position in AbbVie in Q2 2013 and held it in 27 quarters.
  • Edge Wealth Management's AbbVie position peaked at $11.7M in Q2 2015.
  • 3,051 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.